Cardiovascular Devices Market to 2016 - Cardiac Rhythm Management (CRM) and Interventional Cardiology Devices to be the Key Revenue Generators - GBI Research Reports

Cardiovascular Devices Market to 2016 - Cardiac Rhythm Management (CRM) and Interventional Cardiology Devices to be the Key Revenue Generators

Cardiovascular Devices Market to 2016 - Cardiac Rhythm Management (CRM) and Interventional Cardiology Devices to be the Key Revenue Generators - GBI Research Reports
Cardiovascular Devices Market to 2016 - Cardiac Rhythm Management (CRM) and Interventional Cardiology Devices to be the Key Revenue Generators
Published Oct 30, 2010
172 pages — Published Oct 30, 2010
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research's new report, 'Cardiovascular Devices Market to 2016 - The Cardiac Rhythm Management (CRM) and Interventional Cardiology Devices Segments to be the Key Revenue Generators' provides key data, information and analysis on the global cardiovascular devices market. The report provides market landscape, competitive landscape and market trends information on 10 cardiovascular devices market categories - Cardiac Rhythm Management (CRM), External Defibrillator, Interventional Cardiology, Cardiac Assist Devices, Cardiovascular Surgery, Peripheral Vascular Devices, Cardiovascular Prosthetic Devices, Prosthetic Heart Valve, Electrophysiology, and Cardiovascular Monitoring and Diagnostic Devices. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for seven cardiovascular devices market categories - Cardiac Rhythm Management Devices, Interventional Cardiology, Peripheral Vascular Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology and Cardiovascular Monitoring and Diagnostic Devices.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the cardiovascular devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
- Key players covered include Medtronic, Boston Scientific, St. Jude Medical, Abbott, Cordis Corporation and Terumo.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the cardiovascular devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next being thing in the cardiovascular devices market landscape? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global cardiovascular devices market and the factors shaping it.

  
Source:
Document ID
GBIME0012MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents58
1.1 List of Tables92
1.2 List of Figures112
2 Introduction131
2.1 GBI Research Guidance131
3 Global Cardiovascular Devices : Market Characterization1412
3.1 Global Cardiovascular Devices Market, Revenue ($bn), 2002 2009141
3.2 Global Cardiovascular Devices Market, Revenue ($bn), 2009 2016151
3.3 Global Cardiovascular Devices Market, Key Company Share (%), 2009161
3.4 Global Cardiovascular Devices Market, Key Trends171
3.4.1.1 Cardiac Rhythm Management Devices Market is Under-Penetrated and Offers Huge Growth Opportunity for the Big Players172
3.4.1.2 Emerging Countries Hold the Key to Future Growth in the Cardiovascular Device Market 191
3.4.1.3 Consolidation Taking Place in Electrophysiology and Peripheral Vascular Devices Market through Focused Mergers and Acquisitions by Big Players 202
3.5 Global Cardiovascular Devices, Market Dynamics221
3.5.1 Market Drivers221
Rising Incidence of Cardiovascular Diseases Driving the Market 221
3.5.1.2 Population Aged above 60 is Driving the Growth of Overall Cardiovascular Device Market231
3.5.1.3 Increasing Adoption of Minimally Invasive Techniques Boosting Cardiovascular Procedure Volumes241
3.5.1.4 China s New Healthcare Reform Policy is Expected to Propel the Growth of the Cardiovascular Devices Market241
3.5.2 Market Restraints251
3.5.2.1 Reimbursement Cuts and High Cost of Devices Impeding the Growth of the Cardiovascular Device Market251
3.5.2.2 High Percentage of Uninsured Population in Emerging Countries Resulting in Reduced Uptake of Cardiovascular Devices251
4 Global Cardiovascular Devices Market: Category Analysis and Forecasts2646
4.1 Cardiac Rhythm Management Devices261
4.1.1 Cardiac Rhythm Management Devices Market, Global, Revenue ($bn), 2002 2009271
4.1.2 Cardiac Rhythm Management Devices Market, Global, Revenue ($bn), 2009 2016281
Cardiac Rhythm Management Devices Market, Global, Key Company Share (%), 2009291
4.1.4 Cardiac Rhythm Management Devices: Market Dynamics301
4.1.5 Market Drivers301
4.1.5.1 Advanced Technological Innovations in Cardiac Rhythm Management Bolstering the Market Ahead301
4.1.5.2 Favorable Outcomes of Significant Clinical Trials are Expected to Help the ICD Market Grow through Expansion of Device Indication301
4.1.5.3 New Technological Innovations Have Led to Increases in Average Selling Prices311
4.1.5.4 Remote Patient Monitoring a Required Feature in Cardiac Rhythm Management 311
4.1.5.5 Robust Pipeline Products from Several Key Players Would Augment Future Growth in Revenues321
4.1.6 Market Restraints331
4.1.6.1 Low Penetration in Emerging Markets Continues to Negatively Affect Overall Revenues331
4.1.6.2 High Cost of Device Restraining Uptakes331
4.2 Interventional Cardiology341
4.2.1 Interventional Cardiology Market, Global, Revenue ($bn), 2002 2009351
4.2.2 Interventional Cardiology Market, Global, Revenue ($bn), 2009 2016361
4.2.3 Interventional Cardiology Market, Global, Key Company Share (%), 2009371
4.2.4 Interventional Cardiology: Market Dynamics381
4.2.5 Market Drivers381
4.2.5.1 Greater Surgeon Adoption Rate for Minimally Invasive Procedures Responsible for Surge in Interventional Cardiology Devices Market381
Robust Pipeline in Interventional Cardiology Devices is expected to Bring New Products and Increase Competition in the Global Market 381
4.2.5.3 Drug Eluting Stents to Continue Driving the Market Growth due to High Surgeon Adoption Rates391
4.2.5.4 Technological Advancements Such as Bioabsorbable Stents Expected to Drive the Global Coronary Stent Market391
4.2.5.5 Increased Catheterization Procedures Leading to Overall Market Growth 391
4.2.6 Market Restraints401
4.2.6.1 Negative Clinical Outcomes and Complications of In-Stent Re-Stenosis have Affected the Growth of the Market401
4.2.6.2 Re-stenosis is Acting as a Deterrent to Increased Uptake of Coronary Stents Volumes401
4.2.6.3 Alternative Treatment Options and Preference of Pharmacological Therapies is Minimizing the Need for PCI Procedures 401
4.3 Peripheral Vascular Devices411
4.3.1 Peripheral Vascular Devices Market, Global, Revenue ($m), 2002 2009421
4.3.2 Peripheral Vascular Devices Market, Global, Revenue ($m), 2009 2016431
4.3.3 Peripheral Vascular Devices Market, Global, Key Company Share (%), 2009441
4.3.4 Peripheral Vascular Devices: Market Drivers451
4.3.4.1 Increasing Detection and Treatment of Abdominal Aortic Aneurysms Contributing to the Growth of Aortic Stent Graft Market 451
4.3.4.2 New Products and Techniques that Improve Clinical Outcomes to Boost Adoption Rates of Various Peripheral Vascular Devices451
4.3.4.3 Increased Adoption Rate for Endovascular Aortic Repair To Drive the Procedure Volumes in Aortic Aneurysm Repair451
4.3.4.4 Transition from Surgical Clipping to Endovascular Coiling is Leading to Increased Growth in Embolic Protection Devices Market461
4.3.5 Market Restraints461
4.3.5.1 Requirement of Highly Skilled Surgeons due to the Complexities Associated with Peripheral Vascular Procedures is Limiting the Growth of Procedure Volumes. 461
4.3.5.2 Lack of Adequate Reimbursement in Emerging Countries and Regulatory Policies in Japan are Deterring the Growth of Peripheral Vascular Devices Market. 461
4.4 Cardiovascular Prosthetic Devices471
4.4.1 Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2002 2009481
4.4.2 Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2009 2016491
4.4.3 Cardiovascular Prosthetic Devices Market, Global, Key Company Share (%), 2009501
4.4.4 Cardiovascular Prosthetic Devices: Market Drivers511
4.4.4.1 Innovative Products with New Technologies to Drive Adoption of Tissue Heart Valves511
4.4.4.2 Encouraging Clinical Trial Outcomes of Transcatheter Heart Valve Technology are Expected to Result in Increased Procedure Volumes in High Risk Patients511
4.4.4.3 New Product Approvals and Technology Changes in Cardiac Assist Devices Expected to Bolster Future Adoption Rates 521
4.4.5 Market Restraints521
4.4.5.1 Lack of Robust Clinical Data will Increase Diversity of Opinion Regarding Valvular Disease Management521
4.4.5.2 Lack of Clarity on Reimbursement of Transcatheter Heart Valves (THV) May Deter Higher Uptake of the Devices521
4.5 Cardiovascular Surgery Devices531
4.5.1 Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2002 2009541
4.5.2 Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2009 2016551
4.5.3 Cardiovascular Surgery Devices Market, Global, Key Company Share (%), 2009561
4.5.4 Cardiovascular Surgery Devices: Market Drivers571
4.5.4.1 New Technological Advances and Techniques in Cardiovascular Surgery Expected to Drive Future Adoption Rates571
4.5.4.2 On Pump Surgeries to Boost Market Revenues in the Emerging Countries581
4.5.4.3 CABG as the Only Choice in Case of Failed PCI Procedures and for Post Infarction Patients to Sustain the Market Growth581
4.5.5 Market Restraints581
4.5.5.1 Advances in Catheter Based Interventions, Increased Patient and Surgeon Preference for PCI have Stunted the Cardiovascular Surgery Devices Market Growth581
4.5.5.2 Increased Interest in the Interventional Cardiology Sphere by Major Companies and Investors Shifting the Focus away from Cardiovascular Surgery Devices581
4.5.5.3 Cardiovascular Surgery Requires a High Degree of Skill, Which is Leading to Low Surgeon Preference591
4.6 Electrophysiology591
4.6.1 Electrophysiology Market, Global, Revenue ($m), 2002 2009601
4.6.2 Electrophysiology Market, Global, Revenue ($m), 2009 2016611
4.6.3 Electrophysiology Market, Global, Key Company Share (%), 2009621
4.6.4 Electrophysiology: Market Drivers631
4.6.4.1 Increasing Applications of Electrophysiology Having a Positive Impact on the Market631
4.6.4.2 Growing Adoption Rates of Electrophysiology as a Treatment Modality to Drive the Market 631
4.6.4.3 New Product Approvals and Technological Advances to Boost the Electrophysiology Market631
4.6.4.4 Population above the Age of 60 is Leading to Increased Patient Pool Suffering from Atrial Fibrillation641
4.6.5 Market Restraints651
4.6.5.1 Under Diagnosis and Under Penetration Only 30% of US Electrophysiologists Perform Ablation Procedures.651
4.6.5.2 Increased Use of Reprocessed Catheters would Negatively Affect the Overall Revenues in the US and Europe 651
4.6.5.3 Lack of Skilled and Trained Professionals would Negatively Affect the Procedure Volumes651
4.6.5.4 Huge Initial Set-Up Costs for Hospitals Resulting in Inadequate Number of Electrophysiology Centers in Developing Countries 651
4.7 Cardiovascular Monitoring and Diagnostic Devices661
4.7.1 Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m), 2002 2009671
4.7.2 Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m), 2009 2016681
4.7.3 Cardiovascular Monitoring and Diagnostic Devices Market, Global, Key Company Share (%), 2009691
4.8 Cardiovascular Monitoring and Diagnostic Devices: Market Dynamics701
4.8.1 Market Drivers701
4.8.1.1 Advancements in Technology Boost Demand within the Cardiovascular Monitoring and Diagnostic Devices Market701
4.8.1.2 Rising Number of Physician Offices Leading to Additional Sale of ECG Monitoring Devices701
4.8.1.3 Rising Incidence of Cardiovascular Diseases Resulting in Significant Growth of Diagnostic and Monitoring Tests701
4.8.1.4 Growing Usage of Diagnostic and Monitoring Devices for Cardiovascular Disease Testing as Emphasis on Preventive Care Increases701
4.8.2 Market Restraints711
4.8.2.1 Maturity of the Market Limits Growth and Innovation Capacities for the Future711
4.8.2.2 Strategies to Reduce Infrastructure Expenditure by Hospitals has led to Decrease in Value of Diagnostic and Monitoring Devices Market711
5 Global Cardiovascular Devices Market: Country Analysis and Forecasts7227
Cardiovascular Devices Market: Cross-Country Analysis721
5.2 Historic (2002 2009) and Forecast (2009-2016) Revenue, By Country731
5.2.1 Cardiovascular Devices Market, US, Revenue ($bn), 2002 2009731
5.2.2 Cardiovascular Devices Market, US, Revenue ($bn), 2009 2016741
5.2.3 Cardiovascular Devices Market, Canada, Revenue ($m), 2002 2009751
5.2.4 Cardiovascular Devices Market, Canada, Revenue ($m), 2009 2016761
5.2.5 Cardiovascular Devices Market, UK, Revenue ($m), 2002 2009771
5.2.6 Cardiovascular Devices Market, UK, Revenue ($m), 2009 2016781
5.2.7 Cardiovascular Devices Market, Germany, Revenue ($m), 2002 2009791
5.2.8 Cardiovascular Devices Market, Germany, Revenue ($m), 2009 2016802
5.2.9 Cardiovascular Devices Market, France, Revenue ($m), 2002 2009821
5.2.10 Cardiovascular Devices Market, France, Revenue ($m), 2009 2016831
5.2.11 Cardiovascular Devices Market, Italy, Revenue ($m), 2002 2009841
5.2.12 Cardiovascular Devices Market, Italy, Revenue ($m), 2009 2016852
5.2.13 Cardiovascular Devices Market, Spain, Revenue ($m), 2002 2009871
5.2.14 Cardiovascular Devices Market, Spain, Revenue ($m), 2009 2016881
5.2.15 Cardiovascular Devices Market, Brazil, Revenue ($m), 2002 2009891
5.2.16 Cardiovascular Devices Market, Brazil, Revenue ($m), 2009 2016901
5.2.17 Cardiovascular Devices Market, Japan, Revenue ($m), 2002 2009911
5.2.18 Cardiovascular Devices Market, Japan, Revenue ($m), 2009 2016921
5.2.19 Cardiovascular Devices Market, China, Revenue ($m), 2002 2009931
5.2.20 Cardiovascular Devices Market, China, Revenue ($m), 2009 2016941
5.2.21 Cardiovascular Devices Market, India, Revenue ($m), 2002 2009951
5.2.22 Cardiovascular Devices Market, India, Revenue ($m), 2009 2016961
5.2.23 Cardiovascular Devices Market, Australia, Revenue ($m), 2002 2009971
5.2.24 Cardiovascular Devices Market, Australia, Revenue ($m), 2009 2016981
6 Global Cardiovascular Devices Market: Competitive Assessment998
6.1 Medtronic, Inc1001
6.1.1 Business Overview1001
6.1.2 Key Marketed Products1001
6.2 Boston Scientific Corporation1011
6.2.1 Business Overview1011
6.2.2 Key Marketed Products1011
6.3 St. Jude Medical, Inc.1021
6.3.1 Business Overview1021
6.3.2 Key Marketed Products1021
6.4 Abbott 1031
6.4.1 Business Overview1031
6.4.2 Key Marketed Products1031
6.5 Cordis1031
6.5.1 Business Overview1031
6.5.2 Key Marketed Products1031
6.6 Terumo Corporation1041
6.6.1 Business Overview1041
6.6.2 Key Marketed Products1041
6.7 Sorin Group1041
6.7.1 Business Overview1041
6.7.2 Key Marketed Products1041
6.8 Edwards Lifesciences Corporation1041
6.8.1 Business Overview1041
6.8.2 Key Marketed Products1041
6.9 C.R. Bard, Inc.1051
6.9.1 Business Overview1051
6.9.2 Key Marketed Products1051
6.10 Biosense Webster, Inc.1051
6.10.1 Business Overview1051
6.10.2 Key Marketed Products1051
6.11 BIOTRONIK SE &Co. KG1061
6.11.1 Business Overview1061
6.11.2 Key Marketed Products1061
7 Global Cardiovascular Devices Market: Product Pipeline Analysis10755
7.1 Cardiovascular Rhythm Management Devices1071
7.2 Cardiac Rhythm Management Devices: List of Pipeline Products1083
7.3 Profiles of Key Pipeline Products: Cardiac Rhythm Management1111
7.3.1 Pacemakers1111
7.3.1.1 Advisa DR1111
7.3.1.2 Reply MRI1111
7.3.1.3 Accent MRI1111
7.3.1.4 Ensure MRI1121
7.3.2 Implantable Cardioverter Defibrillator1121
7.3.2.1 Fortify ST1121
7.3.2.2 Paradym DR1121
7.3.2.3 Protecta XT VR1121
7.3.3 Cardiac Resynchronization Therapy1131
7.3.3.1 Promote Q1131
7.3.3.2 Paradym RF 1131
7.3.3.3 Protecta CRT-D 1131
7.4 Cardiac Monitoring and Diagnostic Devices1141
7.5 Cardiovascular Diagnostic and Monitoring Devices: List of Pipeline Products1152
7.6 Profiles of Key Pipeline Products: Cardiovascular Monitoring and Diagnostic Devices1171
7.6.1 ECG Monitoring Equipment1171
7.6.1.1 AngelMed Guardian System1171
7.6.1.2 dBG 3001181
7.6.2 Event Monitoring System1181
7.6.2.1 SupraQ1181
7.6.3 ECG Stress Testing Systems1181
7.6.3.1 CVInsight1181
7.6.4 Holter Monitoring Systems1181
7.6.4.1 Fidelity 350 Holter Monitor1181
7.6.4.2 Vectraplex PDA1181
7.7 Cardiovascular Surgery1191
7.8 Cardiovascular Surgery: List of Pipeline Products1201
7.9 Profiles of Key Pipeline Products: Cardiovascular Surgery1211
7.9.1 Cardiopulmonary Bypass Equipment1211
7.9.1.1 C5 HLM1211
7.9.2 Oxygenators1211
7.9.2.1 New Oxy Apex HP oxygenator1211
7.9.3 Perfusion Disposables1211
7.9.3.1 DownStream AO Cartridge1211
7.9.4 Cardiac Ablation Devices1221
7.9.4.1 ClariVein-Vascular Ablation1221
7.10 Interventional Cardiology Devices1221
7.11 Interventional Cardiology: List of Pipeline Products12310
7.12 Profiles of Key Pipeline Products: Interventional Cardiology Devices1331
7.12.1 Coronary Stents1331
7.12.1.1 Combo Bio-engineered Sirolimus Eluting Stent1331
7.12.1.2 Coroflex DEBlue 1331
7.12.1.3 XIENCE NANO1331
7.12.1.4 JST Drug-Eluting Stent1341
7.12.1.5 PROTEX Coronary Stent System1341
7.12.1.6 Genius TAXCOR I1341
7.12.2 Cardiac Catheters1351
7.12.2.1 Angioslide eXtra 1351
7.12.2.2 Funnel Catheter1351
7.12.3 PTCA Balloons1351
7.12.3.1 Zylon Zero-Fold Angioplasty balloon catheter 1351
7.12.3.2 Ostial balloon 1351
7.12.3.3 Avion Bifurcation RX2 1351
7.12.4 Arteriotomy Closure Devices 1351
7.12.4.1 CloSys Hemostasis Device 1351
7.12.4.2 EpiClose Plus 1361
7.12.5 Coronary Guidewires1361
7.12.5.1 Variable Control Guidewire System1361
7.12.5.2 Safe-Cross RF CTO System-next generation1361
7.13 Cardiovascular Prosthetic Devices1371
7.14 Cardiovascular Prosthetic Devices: List of Pipeline Products1384
7.15 Profiles of Key Pipeline Products: Cardiovascular Prosthetic Devices1421
7.15.1 Prosthetic Heart Valves1421
7.15.1.1 Polymer Heart Valve1421
7.15.1.2 Ventor Embracer1421
7.15.1.3 CoreValve ReValving System1421
7.15.1.4 Edwards SAPIEN Transcatheter Heart Valve1431
7.15.2 Cardiac Valve Repair 1431
7.15.2.1 MitraClip Device1431
7.15.2.2 BACE (Basal Annuloplasty of the Cardia Externally)1431

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Cardiovascular Devices Market to 2016 - Cardiac Rhythm Management (CRM) and Interventional Cardiology Devices to be the Key Revenue Generators" Oct 30, 2010. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Cardiovascular-Devices-Market-to-2016-Cardiac-Rhythm-Management-CRM-and-Interventional-Cardiology-Devices-to-be-the-Key-Revenue-Generators-2115-110>
  
APA:
GBI Research Reports. (2010). Cardiovascular Devices Market to 2016 - Cardiac Rhythm Management (CRM) and Interventional Cardiology Devices to be the Key Revenue Generators Oct 30, 2010. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Cardiovascular-Devices-Market-to-2016-Cardiac-Rhythm-Management-CRM-and-Interventional-Cardiology-Devices-to-be-the-Key-Revenue-Generators-2115-110>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.